-
PhRMA
4/8/2013 11:01:00 PM
Share This
America’s biopharmaceutical research companies are developing 907 biologics targeting more than 100 diseases.
Download full rePORT
With more biologic medicines becoming available to treat a broad range of health conditions, it’s important to understand how these complex, “large-molecule” medicines differ from small-molecule medicines people may be more familiar with.